v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue $ 89,001 $ 27,482 $ 212,416 $ 71,951
Cost of revenue 7,502 3,278 18,213 9,158
Gross profit 81,499 24,204 194,203 62,793
Operating expenses:        
Research and development expenses 25,964 14,008 58,897 52,793
Selling, general and administrative expenses 47,206 37,582 147,129 115,748
Operating income (loss) 8,329 (27,386) (11,823) (105,748)
Financing on prepaid forward obligation (4,546) (4,621) (13,597) (13,848)
Interest expense on long-term debt (4,836) (3,373) (13,908) (11,573)
Interest and other income, net 607 979 1,814 4,392
Loss before income taxes (446) (34,401) (37,514) (126,777)
Income tax (expense) benefit (1,016) 1,054 (1,873) (353)
Net loss (1,462) (33,347) (39,387) (127,130)
Statements of comprehensive loss        
Net loss (1,462) (33,347) (39,387) (127,130)
Other comprehensive loss        
Unrealized income (loss) on investments 1 17 (20) (33)
Comprehensive loss $ (1,461) $ (33,330) $ (39,407) $ (127,163)
Net loss per ordinary share - basic and diluted (in dollars per share) $ (0.03) $ (0.69) $ (0.78) $ (2.66)
Weighted average number of shares outstanding used in computation of basic and diluted loss per ordinary share (in shares) 50,558,200 48,057,386 50,375,299 47,742,305